N. Garrett

发表

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

Chaim A. Schramm, Cinque S. Soto, J. Mullikin, 2014, Nature.

Germline Ig Gene Repertoire HIV-1 Antibodies Is Not Restricted by the Ability To Develop Broadly Neutralizing

Q. A. Karim, S. Travers, L. Morris, 2015 .

Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV/AIDS Response

P. Drain, N. Garrett, J. Posner, 2019, Clinical Microbiology Reviews.

The arrival of a true point-of-care molecular assay-ready for global implementation?

P. Drain, N. Garrett, Paul K Drain, 2015, The Lancet. Global health.

Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection

Lynn Morris, James E. Crowe, Nigel Garrett, 2018, Cell host & microbe.

Computational analysis of antibody dynamics identifies recent HIV-1 infection.

H. Liao, B. Haynes, M. Robb, 2017, JCI insight.

Effect of Antiretroviral Therapy on the Memory and Activation Profiles of B Cells in HIV-Infected African Women

N. Garrett, C. Riou, S. A. Abdool Karim, 2017, The Journal of Immunology.

Targeted screening of at-risk adults for acute HIV-1 infection in sub-Saharan Africa

W. Miller, N. Garrett, G. Fegan, 2015, AIDS.

Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype

N. Garrett, C. Riou, S. A. Abdool Karim, 2015, The Journal of Immunology.

Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review

N. Garrett, S. A. Abdool Karim, C. Baxter, 2020, The Journal of infectious diseases.

The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: Are there opportunities to intervene?

L. McKinnon, N. Garrett, M. Shey, 2015, Innate immunity.

An evaluation of the performance of OraQuick® ADVANCE Rapid HIV-1/2 Test in a high-risk population attending genitourinary medicine clinics in East London, UK

M. Symonds, N. Garrett, J. Anderson, 2008, International journal of STD & AIDS.

Germline Ig Gene Repertoire HIV-1 Antibodies Is Not Restricted by the Ability To Develop Broadly Neutralizing

Simon A. A. Travers, Q. A. Karim, S. Travers, 2015 .

Metabolic Syndrome After HIV Acquisition in South African Women

C. Gray, N. Garrett, C. Williamson, 2016, Journal of acquired immune deficiency syndromes.

Understanding how community antiretroviral delivery influences engagement in HIV care: a qualitative assessment of the Centralised Chronic Medication Dispensing and Distribution programme in South Africa

P. Drain, N. Garrett, C. Butler, 2020, BMJ Open.

Genome Sequences of Five Novel Neisseria gonorrhoeae Sequence Types Isolated in KwaZulu-Natal, South Africa

N. Garrett, Ravesh Singh, Stanford Kwenda, 2021, Microbiology Resource Announcements.

Cost-effectiveness of adoption strategies for point of care HIV viral load monitoring in South Africa

P. Drain, N. Garrett, J. Dorward, 2020, EClinicalMedicine.

Cost-effectiveness of point-of-care testing with task-shifting for HIV care in South Africa: a modelling study.

P. Drain, N. Garrett, S. A. Abdool Karim, 2020, The lancet. HIV.

Point-of-care viral load testing and differentiated HIV care.

P. Drain, N. Garrett, J. Dorward, 2018, The lancet. HIV.

Impact of an educational video as a consent tool on knowledge about cure research among patients and caregivers at HIV clinics in South Africa

N. Garrett, K. Moodley, G. Nair, 2018, Journal of virus eradication.

Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans

Lindsay N. Carpp, L. Zhao, N. Frahm, 2020, PloS one.

Early evolution of HLA-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C infected women.

C. Gray, S. Karim, N. Garrett, 2017 .

Early evolution of human leucocyte antigen-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C-infected women

C. Gray, N. Garrett, C. Williamson, 2017, AIDS.

Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype

N. Garrett, C. Riou, S. A. Abdool Karim, 2015, The Journal of Immunology.

HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition

L. McKinnon, N. Garrett, S. A. Abdool Karim, 2019, Nature Communications.

Replication Capacity of Viruses from Acute Infection Drives HIV-1 Disease Progression

N. Garrett, C. Williamson, P. Selhorst, 2017, Journal of Virology.

Killer-cell Immunoglobulin-like Receptor (KIR) gene profiles modify HIV disease course, not HIV acquisition in South African women

M. Altfeld, T. Ndung’u, C. Gray, 2015, BMC Infectious Diseases.

Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope

S. Karim, L. Morris, P. Moore, 2017, Journal of Virology.

Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study

N. Garrett, G. Bothamley, A. Boyd, 2012, BMC Infectious Diseases.

Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies

L. Morris, P. Moore, N. Garrett, 2018, Journal of Virology.

Genital inflammation and the risk of HIV acquisition in women.

D. Lauffenburger, S. Karim, N. Garrett, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Protocol for a randomised feasibility study of Point-Of-care HIV viral load testing to Enhance Re-suppression in South Africa: the POwER study

P. Drain, N. Garrett, C. Butler, 2021, BMJ Open.

Rapid disease progression in HIV-1 subtype C-infected South African women.

C. Gray, L. McKinnon, L. Morris, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cervicovaginal Inflammation Facilitates Acquisition of Less Infectious HIV Variants

N. Garrett, C. Williamson, P. Selhorst, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Burden of sexually transmitted infections from acute HIV infection among women in South Africa: Evidence from a prospective cohort study.

S. Karim, N. Garrett, A. Vandormael, 2022, Annals of epidemiology.

Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner

S. Richardson, P. Moore, N. Garrett, 2021, Cell Host & Microbe.

Epigenetic Regulation of BST-2 Expression Levels and the Effect on HIV-1 Pathogenesis

M. Carrington, B. Walker, T. Ndung’u, 2021, Frontiers in Immunology.

Modulation of Female Genital Tract-Derived Dendritic Cell Migration and Activation in Response to Inflammatory Cytokines and Toll-Like Receptor Agonists

N. Garrett, S. A. Abdool Karim, M. Shey, 2016, PloS one.

Protocol for a randomised controlled implementation trial of point-of-care viral load testing and task shifting: the Simplifying HIV TREAtment and Monitoring (STREAM) study

P. Drain, N. Garrett, S. A. Abdool Karim, 2017, BMJ Open.

Residual T cell activation and skewed CD8+ T cell memory differentiation despite antiretroviral therapy-induced HIV suppression.

N. Garrett, C. Riou, S. A. Abdool Karim, 2018, Clinical immunology.

Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage

T. Hope, L. Morris, N. Garrett, 2015, PloS one.

Comparison of the rate and size of HIV-1 viral load blips with Roche COBAS TaqMan HIV-1 versions 1.0 and 2.0 and implications for patient management.

I. Ushiro-Lumb, N. Garrett, V. Apea, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

HIV treatment outcomes among people with initiation CD4 counts >500 cells/µL after implementation of Treat All in South African public clinics: a retrospective cohort study

N. Garrett, J. Dorward, K. Mlisana, 2020, Journal of the International AIDS Society.

Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial

J. Mascola, L. Morris, J. Ledgerwood, 2019, BMJ Open.

Case report: mechanisms of HIV elite control in two African women

P. Moore, N. Garrett, C. Williamson, 2018, BMC Infectious Diseases.

The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis

N. Garrett, C. Butler, C. Bottomley, 2021, The lancet. HIV.

Acceptability of point-of-care viral load testing to facilitate differentiated care: a qualitative assessment of people living with HIV and nurses in South Africa

P. Drain, N. Garrett, J. Dorward, 2020, BMC Health Services Research.

Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner

A. Sette, S. Richardson, P. Moore, 2021, Cell Host & Microbe.

Depression onset and its association with community HIV prevalence: a geospatial and panel analyses of nationally representative South African data, 2015-2017

J. Burns, R. Slotow, F. Tanser, 2022, Journal of Affective Disorders Reports.

Impact of point-of-care testing and treatment of sexually transmitted infections and bacterial vaginosis on genital tract inflammatory cytokines in a cohort of young South African women

L. McKinnon, N. Garrett, S. A. Abdool Karim, 2021, Sexually Transmitted Infections.

Pre-infection plasma cytokines and chemokines as predictors of HIV disease progression

L. McKinnon, N. Garrett, S. A. Abdool Karim, 2022, Scientific reports.

Pregnancy rates and outcomes in a longitudinal HIV cohort in the context of evolving antiretroviral treatment provision in South Africa

N. Garrett, S. A. Abdool Karim, A. Kharsany, 2022, BMC Pregnancy and Childbirth.

Southern African HIV Clinicians Society 2022 guideline for the management of sexually transmitted infections: Moving towards best practice

N. Garrett, L. Bekker, K. Cohen, 2022, Southern African journal of HIV medicine.

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

A. Diacon, H. Mahomed, N. Garrett, 2022, The Lancet.

Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV)

T. Ndung’u, A. Sigal, P. Goulder, 2021, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIV.

A. Sigal, S. Karim, T. de Oliveira, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Successful treatment of acute hepatitis C virus in HIV positive patients using the European AIDS Treatment Network guidelines for treatment duration.

N. Garrett, C. Orkin, J. Dorward, 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention

J. Mascola, L. Morris, A. McDermott, 2022, The Journal of infectious diseases.

Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial

J. Mascola, L. Morris, J. Ledgerwood, 2020, BMJ Open.

Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel

D. Lauffenburger, M. Altfeld, L. Morris, 2015, Mucosal Immunology.

New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency

Lynn Morris, Gwo-Yu Chuang, Peter D. Kwong, 2015, Journal of Virology.

Efficacy and Safety of Tenofovir-Containing Antiretroviral Therapy in Women who Acquired HIV while Enrolled in Tenofovir Gel Prophylaxis Trials

S. Karim, N. Garrett, A. Grobler, 2016, Antiviral therapy.

Plasma concentration of injectable contraceptive correlates with reduced cervicovaginal growth factor expression in South African women

L. McKinnon, A. Leslie, N. Garrett, 2020, Mucosal Immunology.

Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure

C. Leen, D. Pillay, R. Gilson, 2014, The Journal of infectious diseases.

Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis.

O. Laeyendecker, T. Quinn, N. Garrett, 2015, The Journal of infectious diseases.

Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape

L. Morris, Z. Sheng, L. Shapiro, 2020, Cell reports.

Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway

J. Kappes, D. Montefiori, L. Morris, 2019, Front. Immunol..

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection

D. Montefiori, L. Morris, G. Ferrari, 2021, PLoS pathogens.

Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression.

B. Walker, T. Ndung’u, S. Kazer, 2016, Immunity.

Raltegravir treatment response in an HIV-2 infected patient: a case report.

N. Garrett, E. Smit, B. Ferns, 2008, AIDS.

Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis

J. Ravel, T. de Oliveira, N. Garrett, 2021, Frontiers in Immunology.

Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women

Vicki C. Ashley, S. Karim, L. Morris, 2016, AIDS.

Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa

N. Garrett, L. Bekker, L. Fairall, 2022, The Lancet.

High Rate of Asymptomatic Carriage Associated with Variant Strain Omicron

J. Andriesen, N. Garrett, L. Bekker, 2021, medRxiv.

J. Burns, N. Garrett, S. A. Abdool Karim, 2013, AIDS and Behavior.

From Bench to Bedside: Lessons from HIV Natural History Cohort Studies

L. Morris, P. Moore, N. Garrett, 2017 .

Challenges of Diagnosing Acute HIV-1 Subtype C Infection in African Women: Performance of a Clinical Algorithm and the Need for Point-of-Care Nucleic-Acid Based Testing

N. Garrett, C. Williamson, K. Mlisana, 2013, PloS one.

The Protease Inhibitor Lopinavir, Boosted with Ritonavir, as Treatment for COVID-19: A Rapid Review

N. Garrett, C. Butler, J. Dorward, 2020, Antiviral therapy.

Review of preventative HIV vaccine clinical trials in South Africa

N. Garrett, L. Bekker, G. Gray, 2020, Archives of Virology.

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Galit Alter, David C Montefiori, Nigel Garrett, 2018, The Lancet.

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

Lindsay N. Carpp, Allan C. deCamp, J. Mullins, 2022, Nature Medicine.

An Evaluation to Determine the Strongest CD4 Count Covariates during HIV Disease Progression in Women in South Africa

T. Zewotir, N. Garrett, D. North, 2019, Infectious Diseases and Therapy.

Performance of anal cytology in a clinical setting when measured against histology and high-resolution anoscopy findings

N. Garrett, M. Sheaff, M. Nathan, 2010, AIDS.

The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation

Shuntai Zhou, S. Karim, R. Swanstrom, 2019, Science Translational Medicine.

HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth

L. Morris, P. Moore, J. Bhiman, 2018, Cell host & microbe.

Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes

R. Kaul, A. Fauci, J. Ananworanich, 2018, Science Translational Medicine.

HIV-1 Superinfection Resembles Primary Infection.

N. Garrett, D. Sheward, C. Williamson, 2015, The Journal of infectious diseases.

Integrin alpha(4)beta(7) expression on peripheral blood CD4(+) T cells predicts HIV acquisition and disease progression outcomes

R. Kaul, A. Fauci, J. Ananworanich, 2022 .

HIV susceptibility in women: The roles of genital inflammation, sexually transmitted infections and the genital microbiome.

N. Garrett, S. Ngcapu, Lenine J P Liebenberg, 2021, Journal of reproductive immunology.

Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies

Lynn Morris, Chaim A. Schramm, John R Mascola, 2015, Nature Medicine.

Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa

N. Garrett, L. Bekker, A. Goga, 2022, The New England journal of medicine.

HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing Antibodies

L. Morris, P. Moore, N. Garrett, 2022, Journal of virology.

Performance of cepheid GeneXpert HIV-1 viral load plasma assay to accurately detect treatment failure: a clinical meta-analysis.

Youyi Fong, Jilian A Sacks, Mercedes Perez Gonzalez, 2019, AIDS.

Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research.

P. Drain, T. de Oliveira, N. Garrett, 2018, The lancet. HIV.

Early antiretroviral therapy is associated with better viral suppression and less HIV drug resistance after implementation of universal treatment in South Africa.

P. Drain, N. Garrett, J. Dorward, 2019, AIDS research and human retroviruses.

Differentiated service delivery for people using second‐line antiretroviral therapy: clinical outcomes from a retrospective cohort study in KwaZulu‐Natal, South Africa

N. Garrett, J. Dorward, Kelly R. Gate, 2021, Journal of the International AIDS Society.

Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial.

P. Drain, N. Garrett, S. A. Abdool Karim, 2020, The lancet. HIV.

V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC Activity

B. Haynes, S. Karim, L. Morris, 2018, Cell reports.

Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120/MF59 in Adults

M. Andrasik, J. Kublin, M. McElrath, 2021, The New England journal of medicine.

Efficacy of boosted protease inhibitor monotherapy in patients with complex medical problems

N. Garrett, Robert F Miller, S. Edwards, 2007, AIDS.

Diagnostic accuracy of the Alere Afinion AS100 point-of-care assay to screen for non-communicable diseases amongst people living with HIV

P. Drain, N. Garrett, J. Dorward, 2022, Journal of acquired immune deficiency syndromes.

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody

M. Carrington, L. Morris, S. Richardson, 2019, PLoS pathogens.

Advancing STI care in low/middle-income countries: has STI syndromic management reached its use-by date?

N. McGrath, N. Garrett, A. Mindel, 2016, Sexually Transmitted Infections.

Assessment of Antibiotic Resistance and Efflux Pump Gene Expression in Neisseria Gonorrhoeae Isolates from South Africa by Quantitative Real-Time PCR and Regression Analysis

N. Garrett, Ravesh Singh, Stanford Kwenda, 2022, International journal of microbiology.

Beyond syndromic management: Opportunities for diagnosis-based treatment of sexually transmitted infections in low- and middle-income countries

N. Garrett, S. A. Abdool Karim, Ravesh Singh, 2018, PloS one.

Antimicrobial Resistance Mechanisms, Multilocus Sequence Typing, and NG-STAR Sequence Types of Diverse Neisseria gonorrhoeae Isolates in KwaZulu-Natal, South Africa

N. Garrett, Ravesh Singh, Stanford Kwenda, 2021, Antimicrobial agents and chemotherapy.

Performance of TaqMan probes for the detection of sexually transmitted infections in South African women

N. Garrett, Ravesh Singh, K. Mlisana, 2021, African journal of laboratory medicine.

Clinic flow for STI, HIV, and TB patients in an urban infectious disease clinic offering point-of-care testing services in Durban, South Africa

P. Drain, N. Garrett, J. Dorward, 2018, BMC Health Services Research.

High-Resolution Melting Analysis to Detect Antimicrobial Resistance Determinants in South African Neisseria gonorrhoeae Clinical Isolates and Specimens

N. Garrett, Ravesh Singh, Stanford Kwenda, 2022, International journal of microbiology.

Diagnostic accuracy of the Xpert CT/NG and OSOM Trichomonas Rapid assays for point-of-care STI testing among young women in South Africa: a cross-sectional study

N. Garrett, Ravesh Singh, J. Dorward, 2019, BMJ Open.

South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication

S. Karim, L. Morris, S. Richardson, 2015, Retrovirology.

Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses

L. Morris, P. Moore, N. Garrett, 2017, AIDS.

Impact of Antiretroviral Therapy on Health-Related Quality of Life among South African Women in the CAPRISA 002 Acute Infection Study

J. Burns, N. Garrett, S. A. Abdool Karim, 2014, AIDS and Behavior.

HIV Disease Progression in Seroconvertors from the CAPRISA 004 Tenofovir Gel Pre-exposure Prophylaxis Trial

C. Gray, L. Morris, N. Garrett, 2015, Journal of acquired immune deficiency syndromes.

Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies

L. Morris, P. Moore, N. Garrett, 2022, bioRxiv.

Risk Factors for HIV Acquisition in High Risk Women in a Generalised Epidemic Setting

N. Garrett, S. A. Abdool Karim, A. Kharsany, 2015, AIDS and Behavior.

Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial

N. Garrett, I. Sanne, L. Fairall, 2022, PLoS medicine.

High Asymptomatic Carriage With the Omicron Variant in South Africa

J. Andriesen, N. Garrett, L. Bekker, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies

L. Morris, G. Alter, S. Richardson, 2018, PLoS pathogens.

Acceptability of Early Antiretroviral Therapy Among South African Women

S. Karim, N. Garrett, K. Leask, 2018, AIDS and Behavior.

Breakthrough Covid-19 infections during periods of circulating Beta, Delta and Omicron variants of concern, among health care workers in the Sisonke Ad26.COV2.S vaccine trial, South Africa

N. Garrett, L. Bekker, G. Gray, 2021, medRxiv.

Assessing a diagnosis tool for bacterial vaginosis

S. Karim, N. Garrett, Ravesh Singh, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Incidence, recurrence, and prevalence of bacterial vaginosis from acute to chronic HIV infection in a prospective cohort of women in South Africa.

N. Garrett, A. Vandormael, S. A. Abdool Karim, 2023, Annals of epidemiology.

Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection

S. Richardson, P. Moore, N. Garrett, 2023, medRxiv.

Dynamics of raltegravir resistance profile in an HIV type 2-infected patient.

N. Garrett, J. Workman, E. Smit, 2009, AIDS research and human retroviruses.

Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study)

N. Garrett, L. Bekker, I. Sanne, 2023, BMJ medicine.

SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19 in people living with HIV

P. Drain, N. Garrett, 2020, EClinicalMedicine.

Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study

N. Garrett, J. Peter, I. Sanne, 2021, The New England journal of medicine.

Functional characterization of Vif proteins from HIV-1 infected patients with different APOBEC3G haplotypes

T. Ndung’u, N. Garrett, V. Simon, 2016, AIDS.

Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes

P. Drain, N. Garrett, J. Simoni, 2021, BMJ Open.

Genital HSV-1 DNA detection is associated with a low inflammatory profile in HIV-uninfected South African women

N. Garrett, Ravesh Singh, A. Rompalo, 2020, Sexually Transmitted Infections.

Delivery of Community-based Antiretroviral Therapy to Maintain Viral Suppression and Retention in Care in South Africa

P. Drain, N. Garrett, J. Dorward, 2023, Journal of acquired immune deficiency syndromes.

Comparative cost analysis of point-of-care versus laboratory-based testing to initiate and monitor HIV treatment in South Africa

P. Drain, N. Garrett, J. Dorward, 2019, PloS one.

Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women

S. Karim, N. Garrett, Ravesh Singh, 2021, Frontiers in Immunology.

Diagnostic accuracy of the rapid Xpert HIV-1 Viral Load XC, Xpert HIV-1 Viral Load & m-PIMA HIV-1/2 Viral Load in South African clinics

P. Drain, N. Garrett, T. Fanshawe, 2022, Journal of acquired immune deficiency syndromes.

Clinic-Based Evaluation of a Point-of-Care Creatinine Assay to Screen for Renal Impairment Among HIV-Positive Patients Receiving Tenofovir Disoproxil Fumarate

P. Drain, N. Garrett, J. Dorward, 2017, Journal of acquired immune deficiency syndromes.

Diagnostic Accuracy of the Point-of-Care Xpert HIV-1 Viral Load Assay in a South African HIV Clinic

Natasha Samsunder, P. Drain, N. Garrett, 2016, Journal of acquired immune deficiency syndromes.

IMPLEMENTATION AND OUTCOMES OF DOLUTEGRAVIR-BASED FIRST-LINE ANTIRETROVIRAL THERAPY FOR PEOPLE WITH HIV IN SOUTH AFRICA: A RETROSPECTIVE COHORT STUDY

N. Garrett, C. Bottomley, J. Dorward, 2023, The lancet. HIV.

Neutralizing antibodies elicited by the Ad26.COV2.S COVID-19 vaccine show reduced activity against 501Y.V2 (B.1.351), despite protection against severe disease by this variant

H. Schuitemaker, L. Morris, P. Moore, 2021, bioRxiv.

HIV-1 V 1 V 2 antibody with exceptional potency 5 6

Chaim A. Schramm, B. Haynes, G. Chuang, 2015 .

Limited HIV-1 Superinfection in Seroconverters from the CAPRISA 004 Microbicide Trial

T. Quinn, N. Garrett, D. Sheward, 2013, Journal of Clinical Microbiology.

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

Lindsay N. Carpp, Mathieu Le Gars, Ilse C. L. Van Dromme, 2023, Research square.

HIV Vaccine and Passive Immunity Trials

L. Morris, N. Garrett, N. Naicker, 2017 .

Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells

A. Sigal, A. Leslie, S. Richardson, 2023, NPJ vaccines.

Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection

Peter B Polk, D. Richman, A. Anzueto, 2023, Nature communications.

Immunological correlates of the HIV-1 replication-competent reservoir size.

A. Perelson, L. McKinnon, R. Swanstrom, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial

R. Koup, L. Morris, P. Moore, 2023, BMJ open.

Association between regular physical activity and the protective effect of vaccination against SARS-CoV-2 in a South African case–control study

N. Garrett, L. Bekker, J. Patricios, 2022, British Journal of Sports Medicine.

Allergic reactions to the Ad26.COV2.S Vaccine in South Africa

N. Garrett, I. Sanne, A. Goga, 2021, Journal of Allergy and Clinical Immunology: Global.

Erratum: Southern African HIV Clinicians Society 2022 guideline for the management of sexually transmitted infections: Moving towards best practice

N. Garrett, L. Bekker, K. Cohen, 2022, Southern African Journal of HIV Medicine.

Blood monocyte and dendritic cell profiles among people living with HIV with Mycobacterium tuberculosis co-infection

L. McKinnon, N. Garrett, K. Naidoo, 2023, BMC Immunology.

Ability To Develop Broadly Neutralizing HIV-1 Antibodies Is Not Restricted by the Germline Ig Gene Repertoire

Simon A. A. Travers, L. Morris, P. Moore, 2015, The Journal of Immunology.